← Back to Search

Aliviado DSD Program for Dementia Caregivers

N/A

Recruiting

Led By Shih-Yin Lin

Research Sponsored by NYU Langone Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

To be eligible to participate in the feasibility trial, an individual must meet all of the following criteria: Being 18 years old or older, English-speaking, Providing at least 8 hours of unpaid care per week to, or living with, a community dwelling PLWD whose Delirium Risk Assessment Score >=5, Having the capacity to give informed consent, and Having a smartphone with Internet access.

To be eligible as a "dementia caregiver" in the co-design workshop, an individual must: be at least 18 years old, be English-speaking, provide at least 8 hours of unpaid care weekly or live with a community-dwelling PLWD, self-identify as unfamiliar with DSD, have the capacity to consent, and have Internet access

Timeline

Screening 3 weeks

Treatment Varies

Follow Up week 6

Awards & highlights

Study Summary

This trial will develop and test an mHealth program to help family caregivers of dementia patients detect and manage delirium.

Who is the study for?

This trial is for English-speaking adults who provide at least 8 hours of unpaid care weekly or live with someone with dementia at high risk for delirium. They must be unfamiliar with DSD, able to consent, and have internet access via smartphone. Blind or deaf individuals cannot participate.Check my eligibility

What is being tested?

The study tests the 'Aliviado DSD Caregiving Mastery Program,' designed to help family caregivers manage Delirium superimposed on Dementia (DSD) through a mobile health app and educational content over a 5-week workshop.See study design

What are the potential side effects?

Since this intervention involves education and use of an mHealth app rather than medication, traditional side effects are not applicable. However, participants may experience stress or emotional discomfort while learning to manage DSD.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am over 18, speak English, care for someone with dementia without pay, don't know much about DSD, can consent, and have Internet.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ week 6

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~week 6

This trial's timeline: 3 weeks for screening, Varies for treatment, and week 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Modified IBM Computer Usability Satisfaction Questionnaire Score

Number of Participants who Complete Weekly Delirium Screening at Least Twice by Week 6

Number of Participants who Complete all Training Videos by Week 2

+2 more

Secondary outcome measures

Change from Baseline in Caregiver Delirium Knowledge Questionnaire Score at Week 2

Change from Baseline in Caregiver Delirium Knowledge Questionnaire Score at Week 6

Change from Baseline in Center for Epidemiological Studies Depression Scale (CES-D) Score at Week 6

+4 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Family Caregivers of PLWD at High Risk for DeliriumExperimental Treatment1 Intervention

Participants will complete the Aliviado DSD Caregiving Mastery Program. This involves a caregiver education/training period from Week 0 to Week 2, and an implementation period from Week 3 to Week 6.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor

1,369 Previous Clinical Trials

840,568 Total Patients Enrolled

3 Trials studying Delirium

138 Patients Enrolled for Delirium

National Institute on Aging (NIA)NIH

1,675 Previous Clinical Trials

28,020,855 Total Patients Enrolled

35 Trials studying Delirium

38,595 Patients Enrolled for Delirium

Shih-Yin LinPrincipal InvestigatorNYU Rory Meyers College of Nursing

Media Library

Aliviado DSD Caregiving Mastery Program Clinical Trial Eligibility Overview. Trial Name: NCT05630014 — N/A

Delirium Research Study Groups: Family Caregivers of PLWD at High Risk for Delirium

Delirium Clinical Trial 2023: Aliviado DSD Caregiving Mastery Program Highlights & Side Effects. Trial Name: NCT05630014 — N/A

Aliviado DSD Caregiving Mastery Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05630014 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment in this clinical study still available to the public?

"Clinicaltrials.gov shows that this medical research project is no longer recruiting patients, with the original post dating back to December 1st 2022 and the last modification taking place on November 18th 2022. However, there are presently 544 other clinical trials actively looking for participants."

Answered by AI

What is the primary focus of this research endeavor?

"The primary aim of the clinical trial, which will span a time frame of up to 6 weeks, is to measure participants' Program Satisfaction Questionnaire Score. Secondary endpoints include Change from Baseline in DSD Caregiving Mastery Assessment Score at Week 2 (as measured by an adapted version of Pearline's Competence Scale developed by Aliviado), Change from Baseline in Center for Epidemiological Studies Depression Scale (CES-D) Score at Week 6, and Change from Baseline in Caregiver Delirium Knowledge Questionnaire Score at Week 6."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Study of the Aliviado DSD Caregiving Mastery Program

2023. "Study of the Aliviado DSD Caregiving Mastery Program". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05630014.